TCRX - Tscan Therapeutics Inc
Tscan Therapeutics Inc Logo

TCRX - Tscan Therapeutics Inc

https://www.tscan.com
Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Downtrend
Source: Snapshot

None

52W High
$6.22
52W Low
$1.02
MA Status:
50D: Below 200D: Below
Beta (~1 neutral, <0.9 lower risk)
0.99
Valuation
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
0.39
EV/Revenue (<3 favorable)
7.64
P/S (TTM) (<3 favorable)
15.57
P/B (<3 favorable)
0.61
Ownership
Institution‑heavy
Source: Overview
Insiders (1–5% typical)
0.23%
Institutions (25–75% balanced)
79.42%
Shares Outstanding
52,471,000
Float
44,031,300
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
6,961,000
Gross Profit (TTM)
-8,573,000
EPS (TTM)
-1.10
Profit Margin (>10% good)
N/A
Operating Margin (TTM) (higher better)
-12.57%
ROE (TTM) (>15% strong)
-0.63%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
4.74
Momentum
Bearish momentum
Value
0.0231
Previous
0.0351
Trend
Falling
Signal Cross
No cross
As of
Sep. 12, 2025